Insights and opportunities for deep brain stimulation as a brain circuit intervention
- PMID: 37105806
- DOI: 10.1016/j.tins.2023.03.009
Insights and opportunities for deep brain stimulation as a brain circuit intervention
Abstract
Deep brain stimulation (DBS) is an effective treatment and has provided unique insights into the dynamic circuit architecture of brain disorders. This Review illustrates our current understanding of the pathophysiology of movement disorders and their underlying brain circuits that are modulated with DBS. It proposes principles of pathological network synchronization patterns like beta activity (13-35 Hz) in Parkinson's disease. We describe alterations from microscale including local synaptic activity via modulation of mesoscale hypersynchronization to changes in whole-brain macroscale connectivity. Finally, an outlook on advances for clinical innovations in next-generation neurotechnology is provided: from preoperative connectomic targeting to feedback controlled closed-loop adaptive DBS as individualized network-specific brain circuit interventions.
Keywords: brain–computer interface; connectomics; electrocorticography; local field potentials; movement disorders; neurophysiology.
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare the following financial interests/personal relationships that may be considered as potential competing interests. W.J.N. received speaker’s honoraria unrelated to this manuscript from Medtronic, a manufacturer of deep brain stimulation devices, and is a consultant for InBrain, a company developing invasive neuromodulation therapies. A.H. received speaker’s honoraria unrelated to this manuscript from Medtronic, a manufacturer of deep brain stimulation devices. A.A.K. is on the advisory board of Boston Scientific and Medtronic, and has received honoraria unrelated to this manuscript from Boston Scientific, Medtronic, Abbott, Zambon, Stadapharm, Teva and Ipsen, companies manufacturing deep brain stimulation or pharmaceutical therapies.